Huminis, Mary Ann .
HRN: 20-24-63 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2023
CO-AMOXICLAV 625MG (TAB)
08/08/2023
08/15/2023
ORAL
500mg
BID
NSvd
Waiting Final Action